Search results for: 'Analyst Perspective on Agentic AI'

The Internet of Things (IoT) is a complex ecosystem that integrates Information Technology (IT) with Operational Technology (OT) to generate data that can be analysed to increase revenues and improve business productivity. The IoT has moved from the machine-to-machine (M2M) era in which monitoring an asset was the main objective to sensing, gatheri...

2020 created a perfect storm of challenges for the contact center industry. Organizations struggled to deliver on products and services since the COVID-19 pandemic broke out. During this uncertain time, it was even more important to listen and engage with customers and ensure the delivery of continued experiences. To address this, organizations had...

This research service presents the findings on the pharmaceutical market in Ethiopia. The research service presents an overview of the healthcare and pharmaceutical industry structure of the country. The market size and growth of the total Ethiopian pharmaceutical market, including six main therapeutic segments that characterize the prescription dr...

08 Nov 2024  |  Global  |  Market Research

Growth Opportunities in Enterprise Imaging, Global, 2023-2028

Enterprise Imaging is Experiencing Transformational Growth in its Shift to a Cloud-native Software-as-a-Service Business Model with AI Integrations as a Growth Lever

Infographics

×

Medical imaging is no longer limited to radiology, and radiology software solutions are facing challenges in accessing and integrating patient data across health networks. As a result, healthcare providers are adopting enterprise imaging (EI) strategies to consolidate all patient data into a single platform to provide better access and improved dat...

A major challenge in drug discovery is the limited number of gene targets that can be targeted for the development of a drug molecule. Only close to 400 genes are proven targets for US FDA-approved drugs. 80% of human genes are unexplored as targets, and some are considered undruggable. The identification and the selection of novel drug targets (p...

This Market Insight explores how large business process outsourcers (BPOs) are redefining and expanding traditional corporate giving. Corporate social responsibility (CSR) was the decades-long moniker to describe initiatives designed to deeply engage their agents and employees within the local communities. Much more than a company call for donating...

As the industry continues to innovate across novel small- and large-molecule therapies, including RNA-targeted small molecules, cell and gene therapies, and mRNA therapies, pharma sponsors increasingly rely on partners for technology access, database generation and analysis, and preclinical and clinical research.These disruptions continue to drive ...

This report examines how NSFOCUS Intelligent Security Operations Platform (ISOP) helps organizations modernize security operations amid rising cyber threats, expanding alert volumes, and persistent cybersecurity talent shortages. Based on Frost & Sullivan’s independent analysis and customer interviews across banking and telecommunications sectors, ...

As clinical pipelines globally witness a surge in novel complex therapies, the clinical trial industry demands new tools in predictive analytics to improve trial design, planning, and execution. Artificial intelligence is gaining large-scale recognition as support for decentralized trial designs, thus enabling patient-centric clinical trial designs...